Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.
Last trade$1.35
Day change+$0.085 (+6.75%)
Day range$1.23 – $1.35
Volume281,995
Market cap$135M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$135.03M
Price / earnings
—
Price / book
0.93×
Price / sales
0.59×
EV / sales
0.51×
EV / EBITDA
2.45×
Profitability
Earnings per share
-$1.47
Return on assets
-32.18%
Return on equity
-108.2%
Dividend yield
0.24%
Liquidity and leverage
Debt / equity
1.09×
Current ratio
1.96×
Quick ratio
1.96×
Cash ratio
1.43×
Cash flow
Price / cash flow
3.63×
Price / free cash flow
5.58×
Free cash flow
$24.19M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for DH, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$54.65M
$55.2M
$55.93M
$61.53M
$60.05M
$60.75M
$59.19M
$62.29M
Cost of revenue
$12.42M
$14.65M
$14.28M
$14.63M
$14.05M
$14.14M
$15.43M
$14.69M
Gross profit
$42.23M
$40.54M
$41.65M
$46.91M
$45.99M
$46.61M
$43.76M
$47.6M
Selling, general and administrative
$31.51M
$29.96M
$31.66M
$34.46M
$32.74M
$33.14M
$32.92M
$28.88M
Research and development
$6.67M
$6.76M
$6.5M
$9.95M
$7.55M
$7.97M
$9.3M
$8.98M
Total operating expenses
$47.2M
$47.29M
$242.94M
$73.54M
$54.68M
$50.78M
$228.55M
$147.17M
Operating income
-$4.97M
-$6.75M
-$201.29M
-$26.63M
-$8.69M
-$4.17M
-$184.79M
-$99.56M
Interest expense
-$2.66M
-$2.63M
-$2.63M
-$2.87M
-$3M
-$2.99M
-$2.43M
-$3.51M
Income before taxes
-$5.91M
-$7.8M
-$195.79M
-$17.2M
-$17.27M
-$8.81M
-$165.98M
-$90.61M
Income taxes
-$502K
-$345K
-$3.44M
-$53K
$524K
$456K
-$10.89M
-$5.9M
Net income
-$5.41M
-$7.45M
-$192.35M
-$17.15M
-$17.79M
-$9.27M
-$155.09M
-$84.72M
Net income attributable to common shareholders
-$3.89M
-$5.42M
-$138.62M
-$9.32M
-$14.84M
-$7.55M
-$107.23M
-$59.08M
EBITDA
$11.56M
$12.76M
$12.15M
$11.12M
$14.68M
$14.83M
$10.77M
$17.44M
Basic earnings per share
-$0.04
-$0.05
-$1.32
-$0.09
-$0.14
-$0.07
-$0.95
-$0.51
Diluted earnings per share
-$0.04
-$0.05
-$1.32
-$0.09
-$0.14
-$0.07
-$0.95
-$0.51
Recent news
Company coverage with links to the original publishers.
Definitive Healthcare reported Q3 2026 earnings of $0.06 per share, beating consensus estimates of $0.04 by 50%, though revenues slightly exceeded expectations at $54.65 million. However, the company's stock has underperformed significantly, down 57.1% year-to-date versus the S&P 500's 12.3% gain. The stock received a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the market.
Definitive Healthcare announced that it granted inducement awards, including 364,432 time-based restricted stock units, to its new SVP of Growth and Sales Operations, Jeff Moyer, as part of his employment agreement.
Law Offices of Howard G. Smith is investigating Definitive Healthcare Corp. (DH) for possible violations of federal securities laws after the company disclosed a $363.6 million goodwill impairment and reduced its fiscal year 2024 guidance, causing a significant drop in its stock price.
The Law Offices of Frank R. Cruz announced an investigation into Definitive Healthcare Corp. after the company disclosed a $363.6 million goodwill impairment and reduced its 2024 fiscal year guidance, causing a 32.1% drop in its stock price.
The report provides a comprehensive overview of the UK independent healthcare and social care sectors, including data on market value, capacity, trends, leading players, funding sources, and key issues. It highlights the role of private payers and independent sector providers, alongside the public sector, in the funding and delivery of UK health and care services.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.